Cited by 147Bipolar Disorder and TreatmentSuicide and Self-Harm StudiesSchizophrenia research and treatment

Suicidal Behavior During Lithium and Valproate Treatment: A Within-Individual 8-Year Prospective Study of 50,000 Patients With Bipolar Disorder

Open access
Song, Jie, Sjölander, Arvid, Joas, Erik, Bergen, Sarah E., Runeson, Bo, Larsson, Henrik, Landén, Mikael, Lichtenstein, Paul·2017·American Journal of Psychiatry

Abstract

OBJECTIVE: Conclusions regarding lithium's antisuicidal effect for bipolar disorder have been limited due to nonrepresentative subjects and potential confounding factors, including varying severity of illness. Findings regarding the effect of valproate, the most common alternative to lithium, are inconsistent for suicidal behavior. This study investigated the associations of these two drugs with the risk of suicide-related events, and possible differences between drugs, by using within-individual designs in a register-based longitudinal cohort. METHOD: Through linkage of multiple Swedish national registers, 51,535 individuals with bipolar disorder were followed from 2005 to 2013 for treatment with lithium and valproate. Stratified Cox regression was used to estimate the hazard ratios of suicide-related events during treated periods compared with untreated periods. For significant associations between medication and suicide-related events, the population attributable fraction was estimated to assess the public health impact for patients with bipolar disorder. RESULTS: During follow-up, 10,648 suicide-related events occurred. The incidence rate was significantly decreased by 14% during lithium treatment (hazard ratio 0.86, 95% confidence interval [CI] 0.78-0.95) but not during valproate treatment (hazard ratio 1.02, 95% CI 0.89-1.15). The difference in hazard ratios of suicide-related events between lithium and valproate was statistically significant. Estimates of the population attributable fraction suggested that 12% (95% CI 4%-20%) of suicide-related events could have been avoided if patients had taken lithium during the entire follow-up. CONCLUSIONS: The results suggest that lithium should be considered for patients with bipolar disorder with suspected suicidal intentions, although risk for suicide is only one of the considerations when providing clinical care.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1176/appi.ajp.2017.16050542

Cites

36 of 36 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Within-individual designs have shown a 14% decrease in incidence of suicidal acts and completed suicide among people treated with lithium for bipolar disorder.

    “Specific pharmacoepidemiologic approaches, called “within-individual designs,” that account for factors that remain stable in an individual patient (e.g., background genetic risk and environmental adversities) have shown a 14% decrease in the incidence of suicidal acts and completed suicide among people treated with lithium for bipolar disorder65”

    From Suicide (2020) · cites this paper as [65]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Song, J., Sjölander, A., Joas, E., Bergen, S. E., Runeson, B., Larsson, H., Landén, M., & Lichtenstein, P.
Affiliations
Broad Institute (US)
Venue
American Journal of Psychiatry
Published
2017-08-01
Volume
174
Issue
8
Pages
795-802
ISSN
  • 0002-953X (ISSN-L)
  • 1535-7228
OpenAlex
W2622459767
Cited by
147
References
36
Citations by year
2026: 14 · 2025: 11 · 2024: 17 · 2023: 14 · 2022: 18 · 2021: 19 · 2020: 20 · 2019: 14 · 2018: 17 · 2017: 3
FWCI
12.12
Type
journal article
Language
en
Open access
Locations
  • American Journal of Psychiatry (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
  • Social Sciences › Psychology › Clinical Psychology › Suicide and Self-Harm Studies
  • Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
Keywords
bipolar disorder, lithium, valproic acid, suicidal behavior, suicide risk, antisuicidal effects, mood stabilizers, population attributable fraction, suicide prevention
MeSH terms
Suicide Prevention, Adolescent, Adult, Aged, Bipolar Disorder, Female, Humans, Longitudinal Studies, Male, Middle Aged, Registries, Risk, Suicide, Suicide, Attempted, Sulfates, Sweden, Valproic Acid, Proportional Hazards Models, Information Storage and Retrieval, Lithium Compounds, Antimanic Agents, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review